Global In Vitro Diagnostic/IVD Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1943

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
Increasing incidence of sexually transmitted and gastrointestinal diseases coupled with surging demand for large-scale screening, particularly for cancer, is stimulating the growth of the market. IVD helps in detecting whether a particular medicine or treatment would work on a patient.
In 2018, the global In Vitro Diagnostic/IVD market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global In Vitro Diagnostic/IVD status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vitro Diagnostic/IVD development in United States, Europe and China.

The key players covered in this study
Roche Diagnostics (Switzerland)
Siemens Healthineers (Germany)
Danaher Corporation (US)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Johnson & Johnson (US)
Bio-Rad Laboratories (US)
Sysmex Corporation (Japan)
bioMérieux (France)
DiaSorin (Italy)
Ortho Clinical Diagnostics (US)
Agilent Technologies (US)
QIAGEN (Germany)

Market segment by Type, the product can be split into
Instruments
Reagents

Market segment by Application, split into
Diabetes
Oncology
Cardiology
Nephrology

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global In Vitro Diagnostic/IVD status, future forecast, growth opportunity, key market and key players.
To present the In Vitro Diagnostic/IVD development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of In Vitro Diagnostic/IVD are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global In Vitro Diagnostic/IVD Market Size Growth Rate by Type (2014-2025)
1.4.2 Instruments
1.4.3 Reagents
1.5 Market by Application
1.5.1 Global In Vitro Diagnostic/IVD Market Share by Application (2014-2025)
1.5.2 Diabetes
1.5.3 Oncology
1.5.4 Cardiology
1.5.5 Nephrology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 In Vitro Diagnostic/IVD Market Size
2.2 In Vitro Diagnostic/IVD Growth Trends by Regions
2.2.1 In Vitro Diagnostic/IVD Market Size by Regions (2014-2025)
2.2.2 In Vitro Diagnostic/IVD Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 In Vitro Diagnostic/IVD Market Size by Manufacturers
3.1.1 Global In Vitro Diagnostic/IVD Revenue by Manufacturers (2014-2019)
3.1.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global In Vitro Diagnostic/IVD Market Concentration Ratio (CR5 and HHI)
3.2 In Vitro Diagnostic/IVD Key Players Head office and Area Served
3.3 Key Players In Vitro Diagnostic/IVD Product/Solution/Service
3.4 Date of Enter into In Vitro Diagnostic/IVD Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global In Vitro Diagnostic/IVD Market Size by Type (2014-2019)
4.2 Global In Vitro Diagnostic/IVD Market Size by Application (2014-2019)

5 United States
5.1 United States In Vitro Diagnostic/IVD Market Size (2014-2019)
5.2 In Vitro Diagnostic/IVD Key Players in United States
5.3 United States In Vitro Diagnostic/IVD Market Size by Type
5.4 United States In Vitro Diagnostic/IVD Market Size by Application

6 Europe
6.1 Europe In Vitro Diagnostic/IVD Market Size (2014-2019)
6.2 In Vitro Diagnostic/IVD Key Players in Europe
6.3 Europe In Vitro Diagnostic/IVD Market Size by Type
6.4 Europe In Vitro Diagnostic/IVD Market Size by Application

7 China
7.1 China In Vitro Diagnostic/IVD Market Size (2014-2019)
7.2 In Vitro Diagnostic/IVD Key Players in China
7.3 China In Vitro Diagnostic/IVD Market Size by Type
7.4 China In Vitro Diagnostic/IVD Market Size by Application

8 Japan
8.1 Japan In Vitro Diagnostic/IVD Market Size (2014-2019)
8.2 In Vitro Diagnostic/IVD Key Players in Japan
8.3 Japan In Vitro Diagnostic/IVD Market Size by Type
8.4 Japan In Vitro Diagnostic/IVD Market Size by Application

9 Southeast Asia
9.1 Southeast Asia In Vitro Diagnostic/IVD Market Size (2014-2019)
9.2 In Vitro Diagnostic/IVD Key Players in Southeast Asia
9.3 Southeast Asia In Vitro Diagnostic/IVD Market Size by Type
9.4 Southeast Asia In Vitro Diagnostic/IVD Market Size by Application

10 India
10.1 India In Vitro Diagnostic/IVD Market Size (2014-2019)
10.2 In Vitro Diagnostic/IVD Key Players in India
10.3 India In Vitro Diagnostic/IVD Market Size by Type
10.4 India In Vitro Diagnostic/IVD Market Size by Application

11 Central & South America
11.1 Central & South America In Vitro Diagnostic/IVD Market Size (2014-2019)
11.2 In Vitro Diagnostic/IVD Key Players in Central & South America
11.3 Central & South America In Vitro Diagnostic/IVD Market Size by Type
11.4 Central & South America In Vitro Diagnostic/IVD Market Size by Application

12 International Players Profiles
12.1 Roche Diagnostics (Switzerland)
12.1.1 Roche Diagnostics (Switzerland) Company Details
12.1.2 Company Description and Business Overview
12.1.3 In Vitro Diagnostic/IVD Introduction
12.1.4 Roche Diagnostics (Switzerland) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.1.5 Roche Diagnostics (Switzerland) Recent Development
12.2 Siemens Healthineers (Germany)
12.2.1 Siemens Healthineers (Germany) Company Details
12.2.2 Company Description and Business Overview
12.2.3 In Vitro Diagnostic/IVD Introduction
12.2.4 Siemens Healthineers (Germany) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.2.5 Siemens Healthineers (Germany) Recent Development
12.3 Danaher Corporation (US)
12.3.1 Danaher Corporation (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 In Vitro Diagnostic/IVD Introduction
12.3.4 Danaher Corporation (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.3.5 Danaher Corporation (US) Recent Development
12.4 Abbott Laboratories (US)
12.4.1 Abbott Laboratories (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 In Vitro Diagnostic/IVD Introduction
12.4.4 Abbott Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.4.5 Abbott Laboratories (US) Recent Development
12.5 Thermo Fisher Scientific (US)
12.5.1 Thermo Fisher Scientific (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 In Vitro Diagnostic/IVD Introduction
12.5.4 Thermo Fisher Scientific (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.5.5 Thermo Fisher Scientific (US) Recent Development
12.6 Johnson & Johnson (US)
12.6.1 Johnson & Johnson (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 In Vitro Diagnostic/IVD Introduction
12.6.4 Johnson & Johnson (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.6.5 Johnson & Johnson (US) Recent Development
12.7 Bio-Rad Laboratories (US)
12.7.1 Bio-Rad Laboratories (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 In Vitro Diagnostic/IVD Introduction
12.7.4 Bio-Rad Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.7.5 Bio-Rad Laboratories (US) Recent Development
12.8 Sysmex Corporation (Japan)
12.8.1 Sysmex Corporation (Japan) Company Details
12.8.2 Company Description and Business Overview
12.8.3 In Vitro Diagnostic/IVD Introduction
12.8.4 Sysmex Corporation (Japan) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.8.5 Sysmex Corporation (Japan) Recent Development
12.9 bioMérieux (France)
12.9.1 bioMérieux (France) Company Details
12.9.2 Company Description and Business Overview
12.9.3 In Vitro Diagnostic/IVD Introduction
12.9.4 bioMérieux (France) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.9.5 bioMérieux (France) Recent Development
12.10 DiaSorin (Italy)
12.10.1 DiaSorin (Italy) Company Details
12.10.2 Company Description and Business Overview
12.10.3 In Vitro Diagnostic/IVD Introduction
12.10.4 DiaSorin (Italy) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
12.10.5 DiaSorin (Italy) Recent Development
12.11 Ortho Clinical Diagnostics (US)
12.12 Agilent Technologies (US)
12.13 QIAGEN (Germany)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details